High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis

Head and Neck

Volumn 34, Issue 10, 2012, Pages 1450-1455

  Orell Kotikangas, Helena ^a   Schwab, Ursula ^b,c   Ãsterlund, Pia ^a   Saarilahti, Kauko ^a   Mäkitie, Outi ^d   Mäkitie, Antti A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

calcium; cholecalciferol; etiology; oncology; survival

Indexed keywords

CALCIFEDIOL; CALCIUM; PHOSPHATE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CANCER THERAPY; COMORBIDITY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMORBIDITY; FEMALE; FINLAND; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; VITAMIN D DEFICIENCY;

EID: 84866419667     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21954     Document Type: Article

References (54)

1. Zigon G, Berrino F, Gatta G, et al. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study. Ann Oncol 2011; 22: 165-174.
2. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-789. (Pubitemid 47073524)
3. Goon PK, Stanley MA, Ebmeyer J, et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol 2009; 1: 36.
4. Sturgis EM, Wei Q, Spitz MR,. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004; 31: 726-733. (Pubitemid 39602678)
5. Forastiere A, Koch W, Trotti A, Sidransky D,. Head and neck cancer. N Engl J Med 2001; 345: 1890-1900. (Pubitemid 33716564)
6. Iro H, Waldfahrer F,. Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer 1998; 83: 2201-2207. (Pubitemid 28525403)
7. Holick MF,. Vitamin D and bone health. J Nutr 1996; 126: 1159S-1164S. (Pubitemid 26105652)
8. Luong K, Nguyen LT,. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol 2010; 73: 192-201.
9. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696. (Pubitemid 43247139)
10. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997; 8: 615-625. (Pubitemid 27330494)
11. Rossi M, McLaughlin JK, Lagiou P, et al. Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol 2009; 20: 374-378.
12. Lefkowitz ES, Garland CF,. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994; 23: 1133-1136.
13. Hanchette CL, Schwartz GG,. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861-2869.
14. Lipworth L, Rossi M, McLaughlin JK, et al. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol 2009; 20: 1576-1581.
15. Robsahm TE, Tretli S, Dahlback A, Moan J,. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004; 15: 149-158. (Pubitemid 38445361)
16. Zhou W, Heist RS, Liu G, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007; 25: 479-485. (Pubitemid 350002952)
17. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H,. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009; 30: 113-125.
18. Giovannucci E,. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 2008; 624: 31-42.
19. Meier JD, Enepekides DJ, Poirier B, Bradley CA, Albala JS, Farwell DG,. Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg 2007; 133: 1149-1152. (Pubitemid 350157029)
20. Gedlicka C, Hager G, Weissenbock M, et al. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. J Oral Pathol Med 2006; 35: 472-478. (Pubitemid 44212901)
21. Prudencio J, Akutsu N, Benlimame N, et al. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 2001; 93: 745-753. (Pubitemid 32514797)
22. Dunnigan MG, Henderson JB, Hole DJ, Barbara Mawer E, Berry JL,. Meat consumption reduces the risk of nutritional rickets and osteomalacia. Br J Nutr 2005; 94: 983-991. (Pubitemid 43092432)
23. Garland CF, Garland FC,. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9: 227-231. (Pubitemid 11238851)
24. Grant WB,. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003; 164: 371-377.
25. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783. (Pubitemid 28135983)
26. Lips P,. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004; 89-90: 611-614. (Pubitemid 38844358)
27. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R,. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-716. (Pubitemid 40933586)
28. Lamberg-Allardt CJ, Viljakainen H,. Reports of the Ministry of Social affairs and Health. D-vitaminitilanteen seurantatutkimus 2002-2004. Ministry of Social affairs and Health, Helsinki 2006. Available at, http://www.stm.fi/c/ document-library/get-file?folderId=28707&name=DLFE-3594.pdf&title= D-vitamiinitilanteen- seurantatutkimus-2002-2004-fi.pdf.
29. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-816. (Pubitemid 40344442)
30. Hollis BW,. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322. (Pubitemid 40194499)
31. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007; 32: 210-216. (Pubitemid 46223622)
32. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B,. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28. (Pubitemid 44699167)
33. Need AG, Horowitz M, Morris HA, Nordin BC,. Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr 2000; 71: 1577-1581. (Pubitemid 30395907)
34. Lips P,. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501. (Pubitemid 32762324)
35. Brock KE, Graubard BI, Fraser DR, et al. Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr 2010; 64: 280-288.
36. Kauppinen-Makelin R, Tahtela R, Loyttyniemi E, Karkkainen J, Valimaki MJ,. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients. J Intern Med 2001; 249: 559-563. (Pubitemid 32823865)
37. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P,. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000; 11: 847-852.
38. Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA,. Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 2007; 16: 2784-2786. (Pubitemid 351196338)
39. Meyer F, Liu G, Douville P, et al. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer 2011; 128: 1741-1746.
40. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY,. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 2009; 24: 219-224.
41. Heist RS, Zhou W, Wang Z, et al. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008; 26: 5596-5602.
42. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N,. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009; 27: 3757-3763.
43. Rejnmark L, Tietze A, Vestergaard P, et al. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2655-2660.
44. Melamed ML, Michos ED, Post W, Astor B,. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-1637.
45. MacLaughlin J, Holick MF,. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536-1538. (Pubitemid 16193572)
46. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL,. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992; 75: 176-182.
47. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-459.
48. Cui Y, Rohan TE,. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2006; 15: 1427-1437. (Pubitemid 44299311)
49. Schwartz GG,. Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005; 18: 276-289. (Pubitemid 41159577)
50. Schwartz GG, Skinner HG,. Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 2007; 10: 6-11. (Pubitemid 44901127)
51. Akhter J, Chen X, Bowrey P, Bolton EJ, Morris DL,. Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Dis Colon Rectum 1997; 40: 317-321. (Pubitemid 27120140)
52. Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K,. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 1993; 53: 2534-2537. (Pubitemid 23168018)
53. Dalhoff K, Dancey J, Astrup L, et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 2003; 89: 252-257. (Pubitemid 36976311)
54. Beer TM, Ryan CW, Venner PM, et al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol 2007; 25: 669-674. (Pubitemid 350002922)